European equities traded in the US as American depositary receipts were edging down on Thursday morning, declining 0.2% to 1,309.13 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by energy company Equinor (EQNR) and biotech company BioNTech (BNTX), which rose 1.9% and 1.3% respectively.
The decliners from continental Europe were led by pharmaceutical and chemical manufacturer Grifols (GRFS) and pharmaceutical giant Novo Nordisk (NVO), which dropped 4% and 3% respectively.
They were followed by telecoms and consumer electronics company Nokia (NOK), down 2.7%.
From the UK and Ireland, the gainers were led by software development firm Endava (DAVA) and oil and gas major Shell (SHEL), which rose 5.8% and 1.3% respectively.
The decliners from the UK and Ireland were led by biotech companies Silence Therapeutics (SLN) and Compass Pathways (CMPS), which lost 3.1% and 2.8% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。